"Cold" Solid Tumors Become the Proving Ground for a New Generation of Engager and Immune-Priming Therapies
Go back to "Cold" Solid Tumors Become the Proving Ground for a New Generation of Engager and Immune-Priming Therapies| Astellas Pharma Inc Unsponsored ADR (AMEX: ALPMY) | Delayed: 13.47 +0.02 (0.15%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $13.45 | 52 Week High | $19.40 | |||
| Open | $13.48 | 52 Week Low | $12.50 | |||
| Day High | $13.56 | P/E | N/A | |||
| Day Low | $13.45 | EPS | $0.00 | |||
| Volume | 380,312 | |||||
| (NASDAQ: GTBP) | Delayed: 0.49 -0.02 (3.92%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.51 | 52 Week High | $ | |||
| Open | $0.54 | 52 Week Low | $ | |||
| Day High | $0.56 | P/E | N/A | |||
| Day Low | $0.48 | EPS | $ | |||
| Volume | 2,977,492 | |||||
| Oncolytics Biotech, Inc. (NASDAQ: ONCY) | Delayed: 0.92 -0.04 (4.17%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.96 | 52 Week High | $1.37 | |||
| Open | $0.99 | 52 Week Low | $0.24 | |||
| Day High | $1.02 | P/E | N/A | |||
| Day Low | $0.91 | EPS | $0.00 | |||
| Volume | 1,036,335 | |||||
| (NASDAQ: SNSE) | Delayed: 13.85 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $13.85 | 52 Week High | $ | |||
| Open | $13.85 | 52 Week Low | $ | |||
| Day High | $13.85 | P/E | N/A | |||
| Day Low | $13.85 | EPS | $ | |||
| Volume | 3,762,082 | |||||
| (NASDAQ: VIR) | Delayed: 9.57 +0.41 (4.48%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $9.16 | 52 Week High | $ | |||
| Open | $9.29 | 52 Week Low | $ | |||
| Day High | $9.63 | P/E | N/A | |||
| Day Low | $9.16 | EPS | $ | |||
| Volume | 1,793,539 | |||||

